
Tilray Brands (TLRY) | Stock Overview & Key Data
Tilray Brands Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $300.00 on September 17, 2018
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Tilray Brands TLRY | 597.04M Small-cap | 0.00% | 40.48% | 25.53% | -50.00% | -59.59% | -63.13% | -81.14% | -90.73% |
Zoetis ZTS | 68.99B Large-cap | -1.33% | -6.84% | 3.69% | -6.83% | -4.70% | -13.45% | -11.22% | 7.12% |
Haleon Plc - ADR HLN | 45.18B Large-cap | -3.18% | -9.24% | -3.85% | 6.81% | 3.07% | 11.11% | 33.60% | 33.60% |
Indivior PLC INDV | 1.93B Small-cap | 1.38% | 8.46% | 68.83% | 32.59% | 23.04% | 50.05% | 333.89% | 941.33% |
BGM BGM | 1.87B Small-cap | -10.37% | -36.88% | -15.16% | -6.32% | -0.45% | 30.53% | -14.04% | -81.53% |
Supernus SUPN | 1.85B Small-cap | 4.43% | 3.20% | 6.52% | -12.53% | -8.02% | 12.26% | 11.53% | 45.88% |
Ownership & Short Interest
Tilray Brands Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Tilray Brands would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
What is TLRY's 52-week high and low?
In the last 52 weeks, Tilray Brands reached a high of $2.15 (on July 30, 2024) and a low of $0.35 (on June 23, 2025).
What is the market cap and P/E ratio for TLRY?
Curious about Tilray Brands's size and valuation? Its market capitalization stands at 597.04M. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.76, and the forward P/E (looking ahead) is -8.29.
Does TLRY pay dividends? If so, what's the yield?
As for dividends, Tilray Brands isn't currently offering a significant yield, or that specific data isn't available right now.
Who are Tilray Brands's main competitors or similar companies to consider before investing?
When looking at Tilray Brands, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company | Mkt Cap | Sector | Industry | 1Y Return | 3Y Return |
---|---|---|---|---|---|
Zoetis ZTS | 68.99B | Healthcare | Drug Manufacturers - Specialty & Generic | -13.45% | -11.22% |
Haleon Plc - ADR HLN | 45.18B | Healthcare | Drug Manufacturers - Specialty & Generic | 11.11% | 33.60% |
Indivior PLC INDV | 1.93B | Healthcare | Drug Manufacturers - Specialty & Generic | 50.05% | 333.89% |
BGM BGM | 1.87B | Healthcare | Drug Manufacturers - Specialty & Generic | 30.53% | -14.04% |
Supernus SUPN | 1.85B | Healthcare | Drug Manufacturers - Specialty & Generic | 12.26% | 11.53% |
For a more comprehensive list, please see the Peer Performance Comparison table on this page.
What are the key financial health indicators for Tilray Brands Inc.? (e.g., ROE, Debt/Equity)
To get a sense of Tilray Brands's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -30.73%, the Debt to Equity ratio from the most recent quarter is 12.73, and its Gross Profit Margin stands at 28.00%.
What is the recent revenue and earnings growth for TLRY?
Looking at Tilray Brands's growth, its revenue over the trailing twelve months (TTM) was $827M. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.40%, and quarterly earnings saw a YoY growth of -1.36%.
How much of TLRY stock is held by insiders and institutions?
Wondering who owns Tilray Brands stock? Company insiders (like executives and directors) hold about 0.69% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 10.10%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.